ClinicalTrials.gg
Drug

Radium Ra 223 dichloride clinical trials

Also written Xofigo and Radium-223 dichloride.

studies test it
36
open now
0
in phase 3
4
first study started
2004

How each study uses radium Ra 223 dichloride is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Approvals

The first approval found in each region, with its record

United States
15 May 2013 · XOFIGO · NDA 203971 (FDA, Drugs@FDA)
European Union
13 Nov 2013 · Xofigo · EMEA/H/C/002653 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Radium-223 dichloride (Xofigo, BAY88-8223)
14
Radium-223 dichloride (BAY88-8223)
4
Radium Ra 223 Dichloride
2
Ra-223 dichloride
2
Radium-223 chloride (BAY88-8223)
2

Brand

Xofigo
10

Other names

Radium-223 dichloride
7
Alpharadin
5
Radium-223 chloride
2

Studies by the year they started

36 studies that test it; most in 2014 (7)

Studies that test radium Ra 223 dichloride, by start year
YearStudies
20041
20051
20061
20071
20082
20101
20122
20134
20147
20156
20163
20172
20182
20203

By phase

A phase 1/2 study counts in both.

Phase 1
12
Phase 2
23
Phase 3
4
Phase 4
1
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 24 · Other 12

Bayer (23) · M.D. Anderson Cancer Center (3) · University of Utah (2) · Icahn School of Medicine at Mount Sinai (1) · Massachusetts General Hospital (1) · Sir Mortimer B. Davis - Jewish General Hospital (1) · Angela Taber MD (1) · Hoffmann-La Roche (1)

Often tested with

Tested in the same studies.

Abiraterone Acetate (1) · Abiraterone (1) · Prednisone (1) · Cabazitaxel (1) · Carboplatin (1) · Enzalutamide (1) · Denosumab (1) · Hormone Therapy (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Tested against it · 1 phase 3 study under way

Radium Ra 223 dichloride is the comparator. A study of two new drugs counts under both.

  • 1Enzalutamide · Karolinska Institutet · next primary completion Dec 2026
  • 1Abiraterone · Karolinska Institutet · next primary completion Dec 2026
  • 1Carboplatin · Karolinska Institutet · next primary completion Dec 2026
  • 1Docetaxel · Karolinska Institutet · next primary completion Dec 2026
  • 1Niraparib · Karolinska Institutet · next primary completion Dec 2026
  • 1Abiraterone Acetate · Karolinska Institutet · next primary completion Dec 2026
  • 1Prednisone · Karolinska Institutet · next primary completion Dec 2026
  • 1Capivasertib · Karolinska Institutet · next primary completion Dec 2026

Studies

Open first, then newest update. How each study uses radium Ra 223 dichloride is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 36

See all 36 studies that test radium Ra 223 dichloride →

Given beside what is tested · 1 — radium Ra 223 dichloride is usual care or a partner of the new treatment
As the comparator · 2 — what is tested is compared with radium Ra 223 dichloride

Codes

What other systems call radium Ra 223 dichloride · ClinicalTrials.gg INT006278

  • MeSH (NLM) C581106radium Ra 223 dichlorideConfirmed ClinicalTrials.gov, NLM
  • UNII (FDA) RJ00KV3VTGRADIUM RA-223 DICHLORIDEConfirmed FDA, NLM, Wikidata
  • RxNorm 1424174Confirmed FDA, Wikidata
  • Wikidata Q4735269radium ra-223 dichlorideConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C62535Radium Ra 223 DichlorideConfirmed FDA, Wikidata
  • DrugBank DB08913One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.